Market Analysis
Santa Claus Rally: 3 Discounted Stocks Heading into 2026
Pfizer’s comeback, Newmont’s resilience, and Utz’s growth positioning make them compelling candidates for year-end gains.
Total Stories
16
News
PFE
Section
PFE
Market Analysis
Pfizer Shares Fall as 2026 Outlook Reflects Weaker COVID-19 Drug Demand
Pfizer shares fell after the company issued weaker-than-expected 2026 guidance, citing lower demand for COVID-19 products and upcoming patent expirations.
Earnings
Pfizer Tops EPS Expectations in Q3 2025 Despite Revenue Decline
Pfizer reported Q3 2025 revenue of $16.7 billion and adjusted EPS of $0.87, beating expectations and prompting a full-year EPS guidance raise.
Uncategorized
From Defense to Pharma to Energy: Dividend Opportunities Across Sectors
Lockheed’s defense backlog, Pfizer’s biotech expansion, and Schlumberger’s energy contracts make for safe and potentially lucrative dividend plays heading into year-end.
Uncategorized
Pfizer Shares Gain Amid Reports of Deal with the US Government
Pfizer stock climbed over 3% on news of an impending drug-pricing deal with the Trump administration.
Earnings
Pfizer (PFE) Beats Expectations in Q2 2025, Raises EPS Guidance
Pfizer's second-quarter 2025 results exceeded expectations with a 10% revenue growth and an adjusted EPS of $0.78.
Earnings
Pfizer Reports Q1 2025: Revenue Down 8% y/y
Pfizer's Q1 2025 results indicate a sound earnings performance, with adjusted EPS surpassing expectations.
Earnings
Pfizer (NYSE: PFE) Reports Better than Expected Q4 Results
Pfizer Inc. (NYSE: PFE) reported a strong performance for the fourth quarter of 2024, with revenues reaching $17.8 billion.
Market Analysis
Pfizer Targets Up to $64B Revenue in 2025 Amid Strategic Cost Savings
Pfizer projects 2025 revenues between $61 billion and $64 billion, with a focus on cost savings and strategic initiatives to drive growth.
Earnings
Pfizer Inc.’s Strong Q3 Performance: Beats Expectations with $1.06 EPS
Pfizer Inc. reported stellar third-quarter financial results, with revenues surging to $17.7 billion.
Market Analysis
Starboard Value Reportedly Acquires $1B Stake in Pfizer as Stock Lags S&P 500 by 46%
Activist investor Starboard Value has reportedly taken a $1 billion stake in pharmaceutical giant Pfizer.
Earnings
Pfizer Inc. (PFE) Beats Q2 Market Expectations with $13.3 Billion in Revenue
Pfizer Inc. reported a strong Q2 performance in 2024, with total revenues reaching $13.3 billion.
Market Analysis
Stocks to Watch Today: Delta Air Lines, Tesla, and Pfizer
Major market movers today include Delta Air Lines tumbling on weak guidance, Tesla falling amid a debate over its stock performance, and Pfizer rising on development…